Horst Dollinger
Inventor
Stats
- 48 US patents issued
- 57 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 48 US Patents Issued
- 57 US Applications Filed
- 442 Total Citation Count
- Feb 7, 2014 Most Recent Filing
- Sep 2, 1993 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
ALKAHEST, INC. | 2
2 1 | 2010
2012 2014 |
BOEHRINGER INGELHEIM INTERNATIONAL GMBH | 3
1 7 9 3 3 5 3 1 4 | 1995
1997 2004 2005 2006 2007 2008 2010 2012 2013 |
Boehringer Ingelheim KG | 1
3 1 3 1 2 3 3 | 1993
1995 1996 1997 1998 1999 2000 2001 |
Boehringer Ingelheim Pharmaceuticals, Inc. | 1
| 2007
|
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG | 1
2 4 6 1 | 1999
2000 2001 2002 2003 |
Dr. Karl Thomae GmbH | 1
1 | 1995
1996 |
Inventor Addresses
Address | Duration |
---|---|
US | Jul 29, 10 - Jul 29, 10 |
Ingelheim am Rhein, DE | Jan 21, 97 - Jul 04, 02 |
Ingelheim, DE | Apr 01, 97 - Aug 01, 06 |
Ingelheim/Rhein, DE | Jan 19, 99 - May 22, 01 |
Schemmerfen, DE | Dec 02, 10 - Dec 02, 10 |
Schemmerhofen, DE | Jun 05, 03 - Aug 25, 15 |
Schemmerhoffen, DE | Jul 14, 05 - Nov 04, 14 |
Technology Profile
Technology | Matters | |
---|---|---|
A01N: | PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF | 2 |
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 52 |
A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 22 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
9115142 | 2015 | Heterocycle-substituted piperazino-dihydrothienopyrimidines | 0 |
9096579 | 2015 | Amino-indolyl-substituted imidazolyl-pyrimidines and their use as medicaments | 0 |
RE45323 | 2015 | Substituted piperidines as CCR3 antagonists | 2 |
8877756 | 2014 | Substituted pteridines | 0 |
8754073 | 2014 | Substituted piperazino-dihydrothienopyrimidines | 5 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.